Anti-Zebrafish Amyloid-beta A4 protein/app Polyclonal Antibody from ProteoGenix; catalogue ARO-A21976; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Introducing our Anti-Zebrafish Amyloid-beta A4 protein/app Polyclonal Antibody – the essential tool for your biotech research needs.
This highly specific antibody is designed to target the Zebrafish Amyloid-beta A4 protein/app, a key component in the development of Alzheimer’s disease. With its exceptional binding affinity and sensitivity, our antibody allows for accurate detection and analysis of this protein in zebrafish models.
The biological function of the Zebrafish Amyloid-beta A4 protein/app is to promote the formation of amyloid plaques in the brain, a hallmark of Alzheimer’s disease. By targeting this protein, our antibody enables researchers to better understand the mechanisms behind this devastating neurodegenerative disorder.
Our Anti-Zebrafish Amyloid-beta A4 protein/app Polyclonal Antibody has a wide range of applications in biotech research. It can be used in immunohistochemistry, immunofluorescence, and western blotting techniques, making it a versatile tool for various experimental settings.
One of the main advantages of our antibody is its ability to detect the Zebrafish Amyloid-beta A4 protein/app in zebrafish embryos, larvae, and adult tissues. This allows for a comprehensive analysis of the protein’s expression and localization throughout different stages of development.
Furthermore, our antibody has been extensively validated in various zebrafish models, including transgenic and mutant lines. This ensures reliable and reproducible results, giving researchers confidence in their data.
In addition to its applications in Alzheimer’s disease research, our Anti-Zebrafish Amyloid-beta A4 protein/app Polyclonal Antibody has also been used in studies investigating other neurodegenerative disorders, such as Parkinson’s and Huntington’s diseases.
In summary, our Anti-Zebrafish Amyloid-beta A4 protein/app Polyclonal Antibody is a valuable tool for biotech researchers studying Alzheimer’s disease and other neurodegenerative disorders. With its exceptional sensitivity and versatility, it provides reliable and accurate results for a wide range of experimental applications. Trust in our antibody to advance your research and contribute to the understanding of these devastating diseases.
ProteoGenix catalogue number ARO-A21976. For research use only.
Target: Amyloid-beta, Amyloid-beta precursor protein, APP, ABPP, APPI, Alzheimer disease amyloid A4 protein homolog, Alzheimer disease amyloid protein, Amyloid precursor protein, Amyloid-beta (A4) precursor protein, Amyloid-beta A4 protein, Cerebral vascular amyloid peptide, CVAP, PreA4, Protease nexin-II, PN-II, N-APP, Soluble APP-alpha, S-APP-alpha, Soluble APP-beta, S-APP-beta, C99, Beta-secretase C-terminal fragment, Beta-CTF, Amyloid-beta protein 42, Abeta42, Beta-APP42, Amyloid-beta protein 40, Abeta40, Beta-APP40, C83, Alpha-secretase C-terminal fragment, Alpha-CTF, P3(42), P3(40), C80, Gamma-secretase C-terminal fragment 59, Amyloid intracellular domain 59, AICD-59, AID(59), Gamma-CTF(59), Gamma-secretase C-terminal fragment 57, Amyloid intracellular domain 57, AICD-57, AID(57), Gamma-CTF(57), Gamma-secretase C-terminal fragment 50, Amyloid intracellular domain 50, AICD-50, AID(50), Gamma-CTF(50), C31, APP, A4, AD1, Amyloid beta; Clonality: Polyclonal Antibody; Applications: IHC, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Amyloid-beta, Amyloid-beta precursor protein, APP, ABPP, APPI, Alzheimer disease amyloid A4 protein homolog, Alzheimer disease amyloid protein, Amyloid precursor protein, Amyloid-beta (A4) precursor protein, Amyloid-beta A4 protein, Cerebral vascular amyloid peptide, CVAP, PreA4, Protease nexin-II, PN-II, N-APP, Soluble APP-alpha, S-APP-alpha, Soluble APP-beta, S-APP-beta, C99, Beta-secretase C-terminal fragment, Beta-CTF, Amyloid-beta protein 42, Abeta42, Beta-APP42, Amyloid-beta protein 40, Abeta40, Beta-APP40, C83, Alpha-secretase C-terminal fragment, Alpha-CTF, P3(42), P3(40), C80, Gamma-secretase C-terminal fragment 59, Amyloid intracellular domain 59, AICD-59, AID(59), Gamma-CTF(59), Gamma-secretase C-terminal fragment 57, Amyloid intracellular domain 57, AICD-57, AID(57), Gamma-CTF(57), Gamma-secretase C-terminal fragment 50, Amyloid intracellular domain 50, AICD-50, AID(50), Gamma-CTF(50), C31, APP, A4, AD1, Amyloid beta |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
